U.S. Non-Invasive Prenatal Testing (NIPT) Market Size & Share

1. The search results provide a comprehensive market analysis of the U.S. non-invasive prenatal testing (NIPT) industry, projecting growth from $1.04 billion in 2024 to $2.57 billion by 2032 at a CAGR of 12.0%. Key areas covered include:  Market segmentation by product (consumables/reagents, instruments), technology (NGS, microarray, PCR, rolling circular amplification), and end-users (hospitals, clinical laboratories)  Growth drivers like increasing chromosomal disorders, with Down syndrome affecting around 6,000 U.S. babies annually  Expanding test panels and coverage, with approximately 80% of the insured U.S. population now covered for NIPT according to the American College of Obstetricians and Gynecologists  Impact of COVID-19, which initially slowed growth in 2020 but led to increased NIPT adoption in 2021-2022 due to its non-invasive nature  Competitive landscape analysis of key players including Illumina, Natera, and Laboratory Corporation of America Holdings Report- Fortune Business Insights - U.S. Non-invasive Prenatal Testing Market Size Report, 2032 https://www.fortunebusinessinsights.com/u-s-non-invasive-prenatal-testing-nipt-market-108785